Subtype
Colorectal Neoplasm
CI-CAN-00002404Explore in graph →
Non-malignant1,784 active trials21 approved drugs382 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002404Explore in graph →
Clinical trials
8,604 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07048847 | The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer | completed | — | 32 | Izmir Bakircay UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 |
| clinicaltrials |
| NCT03442569 | PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC | completed | Phase 2 | 56 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03630354 | EXERCISING TOGETHER for Couples Coping With Cancer | completed | N/A | 496 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03186326 | Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer(SAMCO) | completed | Phase 2 | 132 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT03584711 | FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation(OPTIPRIME) | completed | Phase 2 | 118 | Federation Francophone de Cancerologie DigestiveOTHER | 2 | Jun 29, 2025 | clinicaltrials |
| NCT03789162 | Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast | completed | — | 850 | Exact Sciences CorporationINDUSTRY | 2 | Jun 29, 2025 | clinicaltrials |
| NCT06414304 | Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy(BLOOMSI) | completed | — | 30 | OncoAtlas LLCINDUSTRY | 1 | Jun 27, 2025 | clinicaltrials |
| NCT05468827 | ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer(ISCAPE) | completed | N/A | 108 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT02824484 | A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE | completed | N/A | 250 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04697394 | CITRuS Stage 1; Feasibility(CITRuS1) | completed | — | 380 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04500171 | Colorectal Cancer Screening Assessment Study | completed | N/A | 264 | University of HawaiiOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT00873275 | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 1 | 11 | City of Hope Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT03267524 | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers | completed | N/A | 87 | City of Hope Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT02368886 | Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 123 | Academic and Community Cancer Research UnitedOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT07026955 | Colorectal Cancer in Young Adults: Study of Incidence, Survival, and Prognostic Factors in Tarragona, Spain(CCR50) | completed | — | 59 | HJ23INDUSTRY | 1 | Jun 18, 2025 | clinicaltrials |
| NCT04625803 | Neoadjuvant Therapy for Locally Advanced Colon Cancer | completed | Phase 2 | 64 | Zhejiang UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT03642067 | Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer | completed | Phase 2 | 59 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT05788484 | A Study of CDX-585 in Patients With Advanced Malignancies | completed | Phase 1 | 20 | Celldex TherapeuticsINDUSTRY | 1 | Jun 15, 2025 | clinicaltrials |
| NCT01804790 | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer(Néofirinox) | completed | Phase 3 | 461 | UNICANCEROTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT07012174 | Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer | completed | — | 142 | Sun Yat-sen UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT07012538 | RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer(RAIPC) | completed | — | 2,640 | Fudan UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT04554836 | MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab | completed | Phase 2 | 6 | TheraOpOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT04616196 | Study of NKTR 255 in Combination With Cetuximab in Solid Tumors | completed | Phase 1 / Phase 2 | 25 | Nektar TherapeuticsINDUSTRY | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05405530 | Nasal Mask Kit in Gastrointestinal Endoscopy(NASO) | completed | N/A | 1,204 | RenJi HospitalOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT03959839 | Endoscopic Submucosal Dissection vs Local Laparoscopic Surgical Resection (TAMIS/TEO) in Early Rectal Neoplasias(DSETAMIS2018) | completed | N/A | 70 | Dr. Alberto Herreros de Tejada EchanojáureguiOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT01493206 | A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer | completed | Phase 2 | 32 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT03037385 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors(ARROW) | completed | Phase 1 / Phase 2 | 590 | Hoffmann-La RocheINDUSTRY | 13 | May 31, 2025 | clinicaltrials |
| NCT04389957 | Improving Colonoscopy Quality for Colorectal Cancer Screening in the National VA Healthcare System | completed | — | 445 | VA Office of Research and DevelopmentFED | 1 | May 30, 2025 | clinicaltrials |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | completed | Phase 1 / Phase 2 | 89 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | May 29, 2025 | clinicaltrials |
| NCT06242197 | Comparing the Effectiveness of Written Vs Verbal Advice for First Degree Relatives of Colorectal Cancer Patients | completed | N/A | 180 | Ramathibodi HospitalOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT05667181 | The Application Value of da Vinci Linear Cutting Stapler SureForm in Robotic Anus Preserving Surgery for Rectal Cancer | completed | N/A | 276 | Nanchang UniversityOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT05801965 | A Digital Therapeutic Solution for Cancer Patients | completed | N/A | 48 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT03206151 | CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer | completed | Phase 3 | 520 | Taizhou Mabtech Pharmaceutical Co.,LtdINDUSTRY | 1 | May 23, 2025 | clinicaltrials |
| NCT06804876 | COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients | completed | Phase 2 | 107 | Zhejiang UniversityOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT04121286 | A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China | completed | Phase 1 | 17 | Allist Pharmaceuticals, Inc.INDUSTRY | 1 | May 20, 2025 | clinicaltrials |
| NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | completed | Phase 2 | 100 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT06978595 | Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies | completed | — | 8,171 | asmaa salama ibrahimOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT02380443 | AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer | completed | Phase 2 | 13 | Mirror Biologics, Inc.INDUSTRY | 1 | May 16, 2025 | clinicaltrials |
| NCT04449679 | Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study | completed | N/A | 34 | Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06324097 | Diagnostic Value of Endocytoscopy for Colorectal Lesions | completed | — | 463 | Hong XuOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT03867409 | The United States Healthy Living Study | completed | N/A | 2,105 | University of FloridaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05658263 | Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet | completed | Early Phase 1 | 14 | University of MinnesotaOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06957574 | Erector Spinae Plane Block as Analgesia in Patients for Colectomy | completed | N/A | 60 | Suez Canal UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT00574353 | Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients | completed | N/A | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT03407417 | A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care | completed | N/A | 960 | University of FloridaOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06137248 | Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption(ROSANNA) | completed | Phase 2 | 76 | University of FloridaOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT02272244 | Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients | completed | N/A | 400 | Thomas Jefferson UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06124131 | Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening(BENEFIT-C) | completed | N/A | 50 | Tulane UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT01972737 | Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer | completed | Phase 1 | 10 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jul 3, 2025source: clinicaltrials